We are building this new website to better deliver information. Find out more. We are building this new website to better deliver information. Find out more.
Let us know what you think.

Updates on 15/02/2019

Meningococcal disease

  • The recommended dose schedule for Bexsero has been updated for healthy infants aged 6 weeks to 5 months. Two primary doses should be given with an 8 week interval between doses, followed by a 3rd dose at 12 months of age.
  • Based on various changes to product information Nimenrix, Menactra, Bexsero and Trumenba, updates have been made, particularly in the Variations from product information.